SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

A sharp XCN price surge and outsized candle are driving attention, with traders buying dips and speculating about a technical squeeze. Others say there is no clear XCN-specific catalyst and point to Bitcoins rebound as a possible factor.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Reports of Irth Capital pursuing a take-private deal with backing from Papa Johns largest U.S. franchisee are driving attention, with traders speculating about whether the board will engage or accept while others doubt a deal will materialize. Frustration over weak sales, the suspended dividend, and the companys declining performance fuels criticism of management and the board.

Annaly Capital Management, Inc. engages in the investment and financing of residential and commercial assets. It operates through the following segments: Agency, Residential Credit, Mortgage Servicing Rights (MSR), and Corporate and Other. The Agency segment invests in agency mortgage-backed securities. The Residential Credit segment is involved in non-agency residential mortgage assets within securitized products and whole loan markets. The MSR segment provides the right to service residential mortgage loans in exchange for a portion of the interest payments made on the loans. The company was founded by Michael A. J. Farrell and Wellington Jamie Denahan-Norris on November 25, 1996 and is headquartered in New York, NY.

Annaly Capital Management Inc

Annalys earnings discussion has centered on a book-value shortfall despite an earnings beat, alongside a sharp share-price slide and fresh lows. Traders are split between treating the high dividend and perceived discount as a buying opportunity and warning that rate volatility and further book-value pressure could make the yield risky.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTechs co-founders plan to leave and start a new mRNA venture, alongside a weak outlook, prompting concerns about leadership, declining COVID-related revenue and the companys ability to advance its oncology pipeline. Some traders view the cash reserves and late-stage cancer programs as a counterweight, leaving the discussion divided between pipeline optimism and doubts about execution.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenus is drawing attention over ESMO Phase 2 data reporting that 72% of patients had no detectable cancer at the six-week assessment after BOT+BAL treatment. Traders are encouraged by the early result but question whether responses will hold on later scans, with broader concerns about the small, nonrandomized studies and the companys execution.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

CCXI is drawing attention as the SPAC vehicle for Agility Robotics, with traders focused on its planned merger and exposure to humanoid robots used in warehouses and factories. Enthusiasm over the robotics theme, commercial deployments and major backers competes with concerns about valuation, losses, execution and typical post-merger SPAC volatility.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costcos strong quarterly results and sales growth have supported bullish interest, but the muted reaction has sparked debate over its premium valuation, slowing membership-fee growth, and the one-time tariff-refund boost. Recent strength is also framed as defensive rotation into consumer staples, while traders watch whether the stock can hold near the psychologically important $1,000 level.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

IGV is attracting attention as software stocks rebound and show relative strength against semiconductors, reviving debate over whether AI will bolster established software businesses rather than disrupt them. Some traders see renewed sector leadership after the SaaSpocalypse selloff, while others view the move as a temporary rotation or warn that resistance could bring a pullback.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Traders are focused on bullish swing and call-option positioning ahead of CVSs upcoming earnings, viewing the recent pullback after an October rebound as a possible pause before further gains. Others warn that the stock is stalling and sellers may take control, leaving the earnings report as the next major test.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSM is under pressure amid doubts about Auvelitys launch for Alzheimers agitation: prescription trends have not accelerated as some investors expected, prompting questions about uptake, depression-treatment growth, and commercial execution ahead of the Nov. 2 quarterly results. Some bulls argue that samples and long-term-care channels may leave reported prescriptions understating demand, while managements silence and broader biotech weakness have added to uncertainty and selling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PLTR I will short $225 - this is the pull back point- Take note and challange me later if it doesnt.

TopOptionsAlerts

Raghunath c balan

StockTwits Web

Palantir Technologies Inc

 I will short $225 - this is the pull back point- Take note and challange me later if it doesnt.

Stock Pivot

Look, 225 is a fair line to test a short. But a line is only a trade if you know where you are wrong. If $PLTR pushes through 225 and holds, the pullback story is done, and adding to the short is the expensive side. If it rejects there, the first step down is the tell. The full plan for that setup, where it is wrong and where it goes next, is worked out on the daily list at https://topoptionsalerts.com

Private VIP options alerts on Telegram. 5 to 6 complete trades every market day: exact contract, entry, stop and two profit targets. Start a 3 day free trial, no card.

Topoptionsalerts

TopOptionsAlerts | Get the options play before the move

Look, 225 is a fair line to test a short. But a line is only a trade if you know where you are wrong. If 

 pushes through 225 and holds, the pullback story is done, and adding to the short is the expensive side. If it rejects there, the first step down is the tell. The full plan for that setup, where it is wrong and where it goes next, is worked out on the daily list at 

@stockpivot with $SPY &amp; $QQQ pull back at 729 and 676, $PLTR should also pull back together?